29895889|t|Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease.
29895889|a|Neuronal loss alongside altered energy metabolism, are key features of Huntington's disease (HD) pathology. The orexigenic gut-peptide hormone ghrelin is known to stimulate appetite and affect whole body energy metabolism. Liraglutide is an efficient anti-type 2 diabetes incretin drug, with neuroprotective effects alongside anorectic properties. Combining liraglutide with the orexigenic peptide ghrelin may potentially promote brain/cognitive function in HD. The R6/2 mouse model of HD exhibits progressive central pathology, weight loss, deranged glucose metabolism, skeletal muscle atrophy and altered body composition. In this study, we targeted energy metabolism in R6/2 mice using a co-administration of liraglutide and ghrelin. We investigated their effect on brain cortical hormone-mediated intracellular signalling pathways, metabolic and apoptotic markers, and the impact on motor function in HD. We here demonstrate that liraglutide, alone or together with ghrelin (subcutaneous daily injections of 150 microg/kg (ghrelin) and 0.2 mg/kg (liraglutide), for 2 weeks), normalized glucose homeostatic features in the R6/2 mouse, without substantially affecting body weight or body composition. Liraglutide alone decreased brain cortical active GLP-1 and IGF-1 levels in R6/2 mice, alongside higher ADP levels. Liraglutide plus ghrelin decreased brain insulin, lactate, AMP and cholesterol levels in R6/2 mice. Taken together, our findings encourage further studies targeting energy metabolism in HD.
29895889	34	41	Ghrelin	Gene	58991
29895889	97	101	R6/2	CellLine	CVCL:9233
29895889	102	107	Mouse	Species	10090
29895889	117	137	Huntington's Disease	Disease	MESH:D006816
29895889	139	152	Neuronal loss	Disease	MESH:D009410
29895889	210	230	Huntington's disease	Disease	MESH:D006816
29895889	232	234	HD	Disease	MESH:D006816
29895889	282	289	ghrelin	Gene	58991
29895889	395	410	type 2 diabetes	Disease	MESH:D003924
29895889	537	544	ghrelin	Gene	58991
29895889	597	599	HD	Disease	MESH:D006816
29895889	605	609	R6/2	CellLine	CVCL:9233
29895889	610	615	mouse	Species	10090
29895889	625	627	HD	Disease	MESH:D006816
29895889	668	679	weight loss	Disease	MESH:D015431
29895889	690	697	glucose	Chemical	MESH:D005947
29895889	719	733	muscle atrophy	Disease	MESH:D009133
29895889	812	816	R6/2	CellLine	CVCL:9233
29895889	817	821	mice	Species	10090
29895889	867	874	ghrelin	Gene	58991
29895889	1044	1046	HD	Disease	MESH:D006816
29895889	1109	1116	ghrelin	Gene	58991
29895889	1166	1173	ghrelin	Gene	58991
29895889	1229	1236	glucose	Chemical	MESH:D005947
29895889	1265	1269	R6/2	CellLine	CVCL:9233
29895889	1270	1275	mouse	Species	10090
29895889	1392	1397	GLP-1	Gene	14526
29895889	1402	1407	IGF-1	Gene	16000
29895889	1418	1422	R6/2	CellLine	CVCL:9233
29895889	1423	1427	mice	Species	10090
29895889	1446	1449	ADP	Chemical	MESH:D000244
29895889	1475	1482	ghrelin	Gene	58991
29895889	1508	1515	lactate	Chemical	MESH:D019344
29895889	1517	1520	AMP	Chemical	MESH:D000249
29895889	1525	1536	cholesterol	Chemical	MESH:D002784
29895889	1547	1551	R6/2	CellLine	CVCL:9233
29895889	1552	1556	mice	Species	10090
29895889	1644	1646	HD	Disease	MESH:D006816
29895889	Negative_Correlation	MESH:D000249	58991
29895889	Negative_Correlation	MESH:D019344	58991
29895889	Association	MESH:D005947	MESH:D006816
29895889	Association	MESH:D006816	58991
29895889	Negative_Correlation	MESH:D002784	58991

